Atlas Trials

A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent

Clinical trial NCT05111509 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05111509
Sponsor
Yusuf Menda
Status
ACTIVE_NOT_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Neuroendocrine Tumor Grade 2Neuroendocrine Tumor Grade 1
Start date
2022-08-22
Primary completion
2026-04-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.